Pfizer-BioNTech Omicron-specific vaccine delayed, but might not be needed

Portfolio
Delivery of Pfizer and BioNTech SE's vaccine to combat the Omicron COVID-19 variant was delayed by several weeks due to a slower-than-expected data gathering process, BionTech Chief Executive Ugur Sahin told Germany's Bild on Thursday, Reuters reported.

Once the vaccine is ready, the company would assess whether it was still needed, Sahin said.

"If the wave ends, that does not mean it can't begin again," he told Bild in a video interview, adding that BioNTech was in a position to continue creating new vaccines as variants emerged if needed.

I really don't see the situation as dramatic anymore,

he said, referring to how the coronavirus would develop in future.

BioNTech had previously expected to launch the vaccine by end of March, but said in late January that this depended on how much clinical data regulators would require.

 

More in Business

Orbán Gábor
August 06, 2025 13:08

Richter CEO: It is sad that the state supports one of our competitors directly

Hungarian drug maker not in an easy spot, according to Gábor Orbán

Richter épulet 2024
August 06, 2025 12:37

Richter closes another strong quarter, here is the new flash report

Hardly any faults with the Hungarian pharma company

GettyImages-1045289894-applikáció-mobil-szállás-szálláshely-turizmus-utazás
August 06, 2025 11:09

Another investigation launched against Booking.com in Hungary

As announced by the Competition Authority

erstekampusz
August 05, 2025 15:30

Erste has made the biggest profit in its history, and another boost may be imminent

The Polish acquisition could give the bank an even bigger momentum

catl
August 04, 2025 16:14

CATL addresses shelving of Hungarian project and layoffs

Managing director gives interview

Lecsapott a GVH a Booking.com-ra
August 04, 2025 08:34

Massive lawsuit launched against Booking.com

Ten thousand hotels are demanding compensation

LATEST NEWS

Detailed search